Zhu Fen, Hwang Byounghoon, Miyamoto Shigeki, Rui Lixin
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Mol Cancer Res. 2017 Mar;15(3):348-357. doi: 10.1158/1541-7786.MCR-16-0344. Epub 2016 Dec 28.
JAKs are non-receptor tyrosine kinases that are generally found in association with cytokine receptors. In the canonical pathway, roles of JAKs have well been established in activating STATs in response to cytokine stimulation to modulate gene transcription. In contrast, a noncanonical role of JAK2 has recently been discovered, in which JAK2 in the nucleus imparts the epigenetic regulation of gene transcription through phosphorylation of tyrosine 41 on the histone protein H3. Recent work further demonstrated that this noncanonical mechanism is conserved with JAK1, which is activated by the autocrine cytokines IL6 and IL10 in activated B-cell-like diffuse large B-cell lymphoma (ABC DLBCL), a cancer type that is particularly difficult to treat and has poor prognosis. However, how JAK1 gains access to the nucleus to enable epigenetic regulation remains undefined. Here, we investigated this question and revealed that JAK1 has a classical nuclear localization signal toward the N-terminal region, which can be recognized by multiple importin α isoforms. Moreover, the nuclear import of JAK1 is independent of its kinase activity but is required for the optimal expansion of ABC DLBCL cells This study demonstrates that the nuclear import of JAK1 is essential for the optimal fitness of ABC DLBCL cells, and targeting JAK1 nuclear localization is a potential therapeutic strategy for ABC DLBCL. .
JAKs是非受体酪氨酸激酶,通常与细胞因子受体相关联。在经典途径中,JAKs在响应细胞因子刺激激活STATs以调节基因转录方面的作用已得到充分确立。相比之下,最近发现了JAK2的一种非经典作用,即细胞核中的JAK2通过组蛋白H3上酪氨酸41的磷酸化赋予基因转录的表观遗传调控。最近的研究进一步表明,这种非经典机制在JAK1中是保守的,JAK1在活化B细胞样弥漫性大B细胞淋巴瘤(ABC DLBCL)中被自分泌细胞因子IL6和IL10激活,ABC DLBCL是一种特别难以治疗且预后较差的癌症类型。然而,JAK1如何进入细胞核以实现表观遗传调控仍不清楚。在这里,我们研究了这个问题,并发现JAK1在其N端区域有一个经典的核定位信号,可被多种输入蛋白α异构体识别。此外,JAK1的核输入与其激酶活性无关,但对于ABC DLBCL细胞的最佳增殖是必需的。这项研究表明,JAK1的核输入对于ABC DLBCL细胞的最佳适应性至关重要,靶向JAK1核定位是ABC DLBCL的一种潜在治疗策略。